27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
- The FDA has classified another recall of Medtronic Plc's (NYSE: MDT) HeartWare HVAD ventricular assist device as a Class I event in light of the potential for serious harm.
- Medtronic is recalling 157 HVAD pump implant kits from the U.S. after receiving complaints that some devices have failed to start or restart promptly. Two deaths have been linked to the fault. Other kits have only restarted after a delay.
- The system consists of an implantable pump and an external controller. The company is recalling the pump implant component of HeartWare in light of 29 complaints about the products.
- Some users detected the faults during pre-implant testing.
- The device's failure could lead to heart attacks, additional procedures, and hospitalizations, as well as worsening heart failure and deaths.
- Price Action: MDT shares are down 0.25% at $117.56 in market trading hours on the last check Tuesday.
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!